Dummy Image

Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data

March 21, 2023 PLOS Covid-19
Dummy Image

Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology

February 14, 2023 Liebert Covid-19
Dummy Image

Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United States

February 10, 2023 PLOS Covid-19
Dummy Image

Real-world performance of SARS-Cov-2 serology tests in the United States, 2020

February 3, 2023 PLOS Covid-19
Dummy Image

Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States

December 1, 2022 JAMA Network Covid-19
Dummy Image

Use of the Postacute Sequelae of COVID-19 Diagnosis Code in Routine Clinical Practice in the US

October 6, 2022 JAMA Network Covid-19
Dummy Image

Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States

September 23, 2022 NIH Covid-19
Dummy Image

Real-world Utilization of SARS-CoV-2 Serological Testing in RNA Positive Patients Across the United States

September 1, 2022 FDA Covid-19
Dummy Image

Data lag in a large open and closed claims dataset: Navigating the completeness-timeliness tradeoff

September 1, 2022 Aetion Other
Dummy Image

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events

August 19, 2022 Oxford Academic Covid-19
Dummy Image

Vital Signs: Hepatitis C Treatment Among Insured Adults

August 9, 2022 CDC Other
Dummy Image

Post–COVID-19 Symptoms and Conditions Among Children and Adolescents

August 5, 2022 CDC COVID-19
Dummy Image

Categorization of COVID-19 severity to determine mortality risk

April 4, 2022 NIH COVID-19
Dummy Image

Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

March 17, 2022 JAMA Network COVID-19
Dummy Image

Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021

January 14, 2022 CDC COVID-19
Dummy Image

Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder

October 29, 2021 Clinicoecon
Outcomes Res
HEOR
Dummy Image

Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2

October 12, 2021 medRxiv COVID-19
Dummy Image

Real-world use and clinical outcomes after 24 weeks of treatment with a prescription digital therapeutic for opioid use disorder

September 3, 2021 Hospital Practice HEOR
Dummy Image

Comparative Effectiveness Of Remdesivir Treatment In Patients Hospitalized With Covid-19

June 20, 2021 ASM COVID-19
Dummy Image

Categorization of COVID-19 Severity to Determine Mortality Risk

May 26, 2021 FDA COVID-19
Dummy Image

Temporal trends in medication utilization among hospitalized COVID-19 patients

May 26, 2021 FDA COVID-19
Dummy Image

Clinical Burden and Practice Patterns in Patients With Chronic Hypoparathyroidism in the United States (US): A Claims Data Analysis Using Diagnosis-Based Criteria

March 20, 2021 Amolyt Pharma Rare disease
Dummy Image

COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients

March 17, 2021 PLOS COVID-19
Dummy Image

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

February 24, 2021 JAMA Network COVID-19
Dummy Image

Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection

December 20, 2020 medRxiv COVID-19
Dummy Image

Diagnosis-wide analysis of COVID-19 complications: An exposure-crossover study

December 8, 2020 CMAJ COVID-19
Dummy Image

Diagnosis-wide analysis of COVID-19 complications: An exposure-crossover study” (reference no. CMAJ-20-1686.R2)

December 08, 2020 CMAJ COVID-19
Dummy Image

Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 240,392 patients hospitalized with COVID-19 in the United States

November 27, 2020 NIH COVID-19
Dummy Image

Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic

November 4, 2020 Pharmacoecon
Outcomes
HEOR
Dummy Image

Comorbid Medical Conditions, Outpatient Healthcare Resource Use, and Charges Associated with Diagnosis of Chronic Insomnia in the US

October 19, 2020 UNC Charlotte Neurology
Dummy Image

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

October 01, 2020 Science Magazine COVID-19
Dummy Image

Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US

July 1, 2020 PLOS COVID-19
Dummy Image

Health Resource Utilization in Advanced Ovarian and Endometrial Cancer in a United States Insurance Claims Database

November 02, 2019 Medidata Oncology
Dummy Image

Prescription Pattern & Physician Propensity for Congestive Heart Failure Treatments in United States & Europe

November 02, 2019 Medidata Cardiology
Dummy Image

Scalable Prediction of Cancer Patient Clinical Events in Real-World Clinical Settings

November 01, 2019 Medidata Oncology
Dummy Image

Using Clinical Data Standards to Facilitate Comparisons of Acute Myeloid Leukemia Treatment Patterns and Outcomes in Real-World Clinical Care and Pooled Clinical Trial Populations

November 01, 2019 Medidata Oncology
Dummy Image

Predicting Chemotherapy-associated Thrombocytopenia In Real World Clinical Settings

August 01, 2019 Medidata Oncology
Dummy Image

Real World Replication Of Clinical Trial Findings In Alzheimer’s Disease

August 01, 2019 Medidata Neurology